Loading
Life sciences · Observational Study
ClinicalTrials.gov · October 15, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Observational Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT04201600). This is a study registration, not published results. Lead sponsor: University of Maryland, Baltimore. Recruitment status: COMPLETED. Study type: OBSERVATIONAL. Enrollment: 66 participants (ACTUAL). Conditions: Glucose Metabolism Disorders (Including Diabetes Mellitus), Cognitive Decline, PreDiabetes, Aging, Alzheimer's Disease. Interventions: DEVICE: Continuous Glucose Monitoring System (CGMS). Primary outcome measures: Aggregate Executive Functioning Score , Day 1; Aggregate Memory Score , Day 1. Brief summary: This study examines the association of variability in glucose values over a 10-day period with cognitive function and AD risk markers among individuals with prediabetes, aged 50 or older.